Live Web Cast on SAGE Crossroads
Presents Debate Over Therapeutic Cloning

With Morton Krondacke serving as moderator for the April 22 event, Washington Post columnist Charles Krautheimer and Michael West, president and CEO of Advanced Cell Technology, debated the impact of science and medical technology on aging. The two high-profile physicians—one a journalist, the other a researcher—focused specifically on the issue of therapeutic cloning during a live Web cast on SAGE Crossroads, sponsored by AAAS/Science and the Alliance for Aging Research. Their debate took place before an audience of journalists and policymakers in the Board Room of the AAAS building, 1200 New York Avenue, NW, Washington, DC.

"Will Therapeutic Cloning Fail or Foster Future Aging Research?" is a program of SAGE Crossroads, the premier online forum for emerging issues of human aging. Launched in March 2003 by AAAS/Science and the Alliance for Aging Research, SAGE Crossroads provides policymakers, journalists and interested consumers with the opportunity to explore the impact of science and technology on aging.

"Medical progress may cure major diseases and extend the life span, but is there a dark side to the promise?" asks Krondacke, explaining the importance of the issues raised on SAGE Crossroads. "What's in your future, as science gets closer to unraveling the process of human aging?"

For more information on SAGE Crossroads and the April 22 cloning debate, see www.sagecrossroads.net.

22 April 2003